• Dermata Therapeutics today announced positive topline results from a completed cosmetic clinical study of its recently launched Tome Foundational Treatment.
• The open-label study enrolled 31 participants using the treatment once weekly for four weeks, showing improvements in skin appearance.
• Participants reported results comparable to professional in-office procedures; the treatment was well tolerated, with no treatment-related adverse events reported.
• Tome Foundational Treatment is available as a one-time purchase of four weekly treatments or through a discounted subscription.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.